Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

Porterhouse BPS logo

Behaviour change: Five things you probably suspected, but weren’t sure about…

Fabrice Allum, managing director of Porterhouse Insights, looks at behaviour change and introduces the Porterhouse BPS.

Porterhouse Medical Group

- PMLiVE

Bayer to challenge Avastin legal ruling

Both sides claim to be acting in patients' best interest

- PMLiVE

Geron poleaxed as partner J&J abandons only pipeline drug

Shares drop by two-thirds as questions raised on imetelstat’s potential

- PMLiVE

FDA approval gained, Pfizer sets sights on first-line NSCLC market

Vizimpro could challenge Tagrisso, survival data will be key

- PMLiVE

Alnylam seeks fast-track filing with biomarker data

Early filing reflects FDA desire for faster approvals

It’s graduation day for Lucid’s inaugural intake of their Futures Academy

Lucid’s Futures Academy programme has come to an end for its inaugural set of graduates. The programme itself kick-started with an intensive 8-week training course back in October last year...

Lucid Group Communications Limited

- PMLiVE

Alexion adds to pipeline with $1.2bn Syntimmune buy

As company prepares for possible loss of patent protection for Soliris

- PMLiVE

Theranexus takes Alzheimer’s drug combo into clinic

150-subject phase 1b trial to start at eight centres in France

- PMLiVE

Call for genetic tests to bring personalised medicine to children with cancer

Action needed as childhood cancer survival has plateaued

Congress Management

Congress Effectiveness Management

Maximising the ROI of scientific meetings

Porterhouse Medical Group

- PMLiVE

Biopharma’s Future: Made in China

The world’s second biggest pharma market is entering a new growth phase – but meeting its needs takes investment and expertise

- PMLiVE

Imfinzi aces survival challenge in lung cancer

Earlier treatment leads to much extended lives, data suggests

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links